PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15089863

Levator function before and after childbirth.

Hans Peter Dietz
View original source ↗Export metadata ↓

Abstract

BACKGROUND: Vaginal childbirth is assumed to affect pelvic floor muscle function as a result of direct trauma and/or neuropathy. AIMS: To assess levator function by ultrasound prior to and after delivery and correlate changes with delivery data. METHODS: A total of 200 nulliparous women were seen at 6-18 and 32-37 weeks' gestation as well as 2-5 months post-partum. Appointments consisted of an interview, paper towel test, flowmetry and translabial ultrasound (supine and after voiding). The most effective of at least three contractions was used for evaluation according to a previously published method quantifying cranioventral displacement of the bladder neck. Labour and delivery details were collected through data collection sheets and the institutional database. RESULTS: A total of 173 women were seen in late pregnancy; 169 returned on average 93 days post-partum. At the last visit, a reduction of cranioventral lift from 11.2 mm (SD 4.5) to 8.8 mm (SD 4.2) was noted (P <0.001) which correlated weakly with active second stage (Spearman's r=-0.196, P=0.013), passive second stage (r=-0.15, P=0.059) and total second stage of labour (r=-0.225, P=0.004). Good antenatal levator function was not protective of changes in levator function or pelvic organ support. CONCLUSIONS: Childbirth reduces bladder neck displacement on levator contraction. The main obstetric determinant affecting levator function seems to be the length of the second stage. A Caesarean section in the second stage appears to exert no protective effect. It seems to be full engagement of the fetal head, not childbirth itself, that impairs levator function.

Explore related subjects

Cohort StudiesDelivery, ObstetricFemaleGestational AgeHumansMuscle ContractionMyometriumObserver VariationParityPelvic FloorPostnatal CarePregnancyPrenatal CareProbabilityProspective StudiesRisk AssessmentUltrasonography, PrenatalComparative StudyJournal ArticleResearch Support, Non-U.S. Gov't

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Hans Peter Dietz. 2004. Levator function before and after childbirth.. https://doi.org/10.1111/j.1479-828x.2004.00140.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study.

Although a link between female hormonal factors and the risk of lung cancer has been suggested, few studies have examined this association in detail. We investigated the associations between reproductive factors, hormone use and the risk of lung cancer in a population-based prospective study. Self-administered questionnaires were distributed to 44,677 lifelong never-smoking women in 1990-1994 to assess menstrual and reproductive factors and hormone use. After 8-12 years of follow-up, 153 lung cancer cases were diagnosed. Relative risk (RR) and 95% confidence intervals (CI) were calculated using the Cox proportional hazards model. Age at menopause, age at menarche, number of children, age at first live birth, breast feeding and use of hormones were not associated with a risk of lung cancer, either overall or among postmenopausal women or women with natural menopause. Compared to women with both late age at menarche (> or =16) and early age at menopause (< or =50), those with either early age at menarche or late age at menopause had a >2-fold, significant increase in the risk of lung cancer. Induced menopausal women with experience of hormone replacement therapy had a significantly elevated risk compared to naturally menopausal women without female hormone use, with an RR of 2.40 (95% CI 1.07-5.40). These findings suggest that both endogenous and extraneous estrogen may be involved in the etiology of lung cancer.

Cohort Studies↗
PubMed2005

Meta-analysis of soy food and risk of prostate cancer in men.

There has been considerable interest in recent years in the role of soy in cancer etiology. The purpose of this meta-analysis was to evaluate epidemiologic studies available to date that related soy consumption to the risk of prostate cancer in men. We conducted a thorough Medline search for English-language publications, supplemented with hand-searching of articles' bibliographies and nonindexed medical and professional journals, on epidemiologic studies of soy and prostate cancer. We identified 2 cohort and 6 case-control studies that met the following criteria for meta-analysis: a study must have assessed soy as a food and provided a risk estimate (relative risk or odds ratio) and its 95% confidence interval. Data from the same study population appearing in different journals were only used once with the most recent publication chosen for the analysis. Studies on fermented soy food were not included. We conducted the meta-analysis using a random-effects model. An analysis of these studies yielded an overall risk estimate of 0.70 (95% CI = 0.59-0.83; p < 0.001). No publication bias was detected. In summary, results of the analysis showed that consumption of soy food was associated with a lower risk of prostate cancer in men.

Cohort Studies↗
PubMed2005

Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse.

High-risk human papillomavirus (hrHPV) types are causally related to cervical cancer and its high-grade precursor lesions. The risk posed by the different hrHPV types for the development of cervical intraepithelial neoplasia grade 2 or worse (> or =CIN2) needs to be established. Here, we present the hrHPV type-distribution in relation to cytology and histology for women participating in a cervical screening program. From 44,102 women who participated in a population-based cervical screening program in the Netherlands, 2,154 hrHPV GP5+/6+ PCR positive women were recruited to determine the distribution of 14 hrHPV types by reverse line blotting of GP5+/6+ PCR products. For each HPV type, associations with cytology and histologically confirmed > or =CIN2 were measured by odds ratios. HPV types 16 and 33 were more prevalent in women, amongst those containing a single hrHPV type, with moderate dyskaryosis or worse (>BMD) than in women with normal cytology, but only in case of underlying > or =CIN2 (OR 4.10, 95%CI 2.98-5.64 and OR 2.68, 95%CI 1.39-5.15, respectively). Similar results were obtained for women with double infections (OR 3.29, 95% CI 1.61-6.75 and OR 4.37, 95% CI 1.17-16.34). Coexisting types did not influence the prevalence of > or =CIN2 in HPV 16 or 33 positive women. The increased prevalence of type 16 and 33 in hrHPV positive women with > or =CIN2, compared to women with normal cytology, suggests that infection with these types confers an increased risk for development of > or =CIN2. Distinguishing these types may therefore have implications for future cervical screening strategies.

Cohort Studies↗